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Abstract: Cavernomas are benign vascular malformations, and about 50% of all cases are 
multiple. The hereditary form of brain cavernomas is uncommon, and it is certainly 
under diagnosed. Another entity is familial cerebral cavernous malformation syndrome. 
It is defined as the occurrence of multiple cavernomas or the occurrence of cavernomas 
in at least two members of a family or the presence of a mutation in one of the three 
genes causing familial cerebral cavernous malformation syndrome. We present a Serbian 
family in which three consecutive members of family had brain cavernoma. According 
to our knowledge, this is second case of hereditary cavernoma described in Serbian 
population. 
Key words: Cavernoma; Familial cerebral cavernous malformation syndrome; multiple 
cavernomas 
 
Introduction 
Cavernomas are a benign vascular 
malformations (e.g. hamartomas), and about 
50% of all cases are multiple (1). They are 
located in the brain or rarely in the spinal cord. 
The size of cavernomas ranges from a few 
millimeters to several centimeters. 
Cavernomas increase or decrease in diameter 
and increase in number over time. The 
majority of cavernomas become apparent 
between the second and fifth decades with 
presentation such as focal neurological defcit, 
headache, seizure, or cerebral hemorrhage (2). 
The hereditary form of cavernomas is 
relatively rare, and this, usually autosomal 
dominant pathology generally presents with 
focal neurological symptoms and seizures, 
however, many patients remain 
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asymptomatic, although, acute hemorrhages 
sometimes appear over time (3). 
We present a Serbian family in which three 
consecutive members of family had brain 
cavernoma. According to our knowledge, this 
is second case of hereditary cavernoma 
described in Serbian population.  
Case presentation 
The first patient is a 35 years old female 
who presented to our emergency department 
with headache, right sided paresthesis, and 
persistent singultus (hiccup). She rated the 
pain as 8 out of 10. A head CT was performed 
and brain stem bleeding was suspected. The 
cranial MRI revealed a cavernoma with signs 
of hemorrhage in the region of medulla 
oblongata and medulla spinalis junction 
(Figure 1).  
 
 
Figure 1. Cranial MRI showing a cavernoma with 
signs of hemorrhage in the region of medulla 
oblongata and medulla spinalis junction. (A) SWI 
sequence. (B) T2 sequence 
 
Corticosteroid therapy was started, and 
symptoms disappeared. However, she had 
occasional attacks of right sided body 
numbness. One year after first onset of 
symptoms, control MRI showed enlargement 
of cavernoma with signs of hemosiderin 
deposits, after which she was accepted for 
stereotactic radio-surgery treatment in 
another hospital, which was performed about 
2 years after the first onset of symptoms. Also, 
she was treated with a total of 1200cGy to 85% 
isodense line to the cavernoma lesion, using 
6D skull IGRT system. She didn’t suffer from 
any side effects, and control MRI showed signs 
of cavernoma regression, without signs of de 
novo hemorrhage (Figure 2). 
 
  
Figure 2. Control MRI with signs of cavernoma 
regression 
 
Her neurological finding was normal, and 
she was without complaints. Control MRI 
after two years showed state after radiation 
therapy, and cavernoma dimensions were 
unchanged. However, SWI MRI sequence was 
performed and multiple brain cavernomas 
without signs of hemorrhage were found, and 
further neuro-radiological follow ups were 
advised. Control MRI was performed in 
another hospital, and we couldnt obtainen the 
images, but only radiological description. 
Also, since multiple cavernomas were found 
on the last MRI, familial form of cerebral 
cavernous malformation was suspected. MRI 
was performed in patient’s father at the age of 
73, and multiple brain cavernomas, without 
sigs of hemorrhage were found (Figure 3). 
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Patient had normal neurological finding, 
and also only follow ups were 
recommended. In further investigation, we 
performed brain MRI in patient’s 15-year 
old son, and single caveroma located in pons 
was found (Figure 4). 
 
 
 
Figure 3. Brain MRI showing multiple cavernomas 
 
 
 
Figure 4. Brain MRI showing caveroma located in 
pons. (A) SWI sequence. (B) DWI sequence 
 
This young patient had normal 
neurological status, and since he is symptom 
free, only regular brain MRI controls are 
recommended. No other members of family 
undergo radiological investigations. 
Discussion 
Brain cavernous malformations or 
cavernous angiomas are vascular 
malformations in the brain or sometimes in 
spinal cord. In one third of patients, these 
cavernous malformations are multiple. The 
hereditary form of brain cavernomas is 
uncommon, and it is certainly under 
diagnosed (3). We present a Serbian family in 
which three consecutive members of family 
had brain cavernoma, of which in 2 members, 
 
 
 
 
 
610 | Vuk et al - Familial cerebral cavernous malformation syndrome in Serbian family 
 
 
 
 
 
 
 
cavernomas were multiple, and one member 
had solitary lesion. 
Another entity is familial cerebral 
cavernous malformation syndrome. It is 
defined as the occurrence of multiple 
cavernomas (usually 5 or more) or the 
occurrence of cavernomas in at least two 
members of a family or the presence of a 
mutation in one of the three genes causing 
familial cerebral cavernous malformation 
syndrome. Three genes are known to cause 
muta¬tions in familial cerebral cavernous 
malformation syndrome: KRIT-1 (CCM-1), 
CCM-2, and PDCD-10 (CCM-3) (Table 1) (3-6). 
 
TABLE I 
Diagnostic criteria’s for familial cerebral 
cavernous malformation syndrome (at least 1 
of the following criteria) 
The presence of multiple brain or spinal cord 
cavernomas (typically 5 or more) 
 
The occurrence of brain or spinal cord 
cavernomas in at least 2 members of a family 
 
The presence of a mutation in one of the three 
genes causing familial cerebral cavernous 
malformation syndrome  
 
 
According to presented criteria’s, this is 
almost typical familial cerebral cavernous 
malformation syndrome, and to our 
knowledge, this is second case of hereditary 
cavernoma described in Serbian population, 
first being described by Mitić et al. (7).  
The disease frequently presents with focal 
neurological deficit (35-50%), and epileptic 
seizures (38-55%) (8). A headache, 
spontaneous paraplegia, or signs of cerebral 
hemorrhage are less frequently encountered 
symptoms and signs. Also, one quarter to one 
half of patients with cavernomas remain 
symptom free during life (9). In presented 
family, one patient had two frequent 
symptoms: headache, and focal neurological 
deficit-parestheis. However, this patient also 
had prolonged hiccups (singultus), which is 
defined as singultus lasting more than 2 days. 
Eisenacher and Spiske presented a similar case 
in which patient had persistent hiccups as the 
presenting symptom of medullary cavernoma. 
Conducting literature review we found two 
more similar cases of persistent cavernoma 
due to presence of medullary cavernoma (10). 
According to described cases, as well as study 
of Musumeci et al, conducted on animals, the 
region of the medulla oblongata lateral of the 
obex is probably responsible for the singultus 
reflex (11). Overall, singultus is rarely 
described in the context of a tumor or vascular 
malformation (e.g. cavernoma) in the region 
of the medulla oblongata, but persistent 
singultus, lasting more than 48 hours should 
arouse suspicion on this rare cause or some 
other rare neurological disorder. 
Genetic testing may confirm suspicion on 
familial cerebral cavernous malformation 
syndrome. Three genes muta¬tions are found 
in this hereditary syndrome: KRIT-1 (CCM-
1), CCM-2, and PDCD-10 (CCM-3) (6). Also, 
this is an autosomal dominant disease, and 
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each child of a person with familial cerebral 
cavernous malformation syndrome has a 50% 
chance of inheriting the mutation. A higher 
incidence of this disease is found in Hispano-
American individuals of Mexican descent, 
probably due to a common ancestor with a 
mutation in the KRIT-1 gene (12). In 
presented family, we didn’t perform genetic 
testing, since family wasn’t motivated.  
In majority of cases, MRI shows multiple 
focal regions of susceptibility induced signal 
loss of different size, well seen on gradient-
echo sequences, or better on susceptibility-
weighted imaging (SWI sequence). Lesion can 
be multiple (about 30% of patients), and in 
familiar form, the number of cavernomas is 
higher, in majority of cases more than 5. 
Number of lesions is increasing with age. 
However, young patients may already have 
numerous cavernomas (13). In our case, MRI 
features of all patients were typical, with SWI 
sequence being most valuable. In two out of 3 
patients from presented family, cavernomas 
were multiple, while the youngest patient had 
only one cavernoma. One patient received 
stereotactic radio-surgery treatment, after 
which neuroradiological follow ups were 
advised. For other two patients only regular 
follow ups were indicated.  
Microsurgical removal of cavernoma is 
may be reasonable if patient has epileptic 
seizures, or focal deficit due to mass effect or 
recurrent bleeding. Stereotactic radiosurgery 
is a safe therapy for cavernomas located in 
deep or eloquent sites (3, 14). It is important to 
find structural and the functional 
abnormalities with data from EEG, MRI, and 
SPECT so the spatial relationships may be 
demonstrated, which can help in the decision 
making for right therapy approach. In 
presented family, one patient had to be 
subjected to stereotactic radiosurgery, since 
she had cavernoma presented with focal 
neurological deficit, and radiological signs of 
repeated bleeding, while other two patients 
were asymptomatic, and only neuro-
radiological follow ups were advised. 
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